24/02/2026
Eswatini's New Research Review Board to Tackle Rare Diseases
By Nokukhanya Musi
Eswatini, a small landlocked country in Southern Africa, is making strides in strengthening its healthcare system. With a population of approximately 1.2 million people, the country faces various health challenges, including infectious diseases like HIV and tuberculosis, as well as non-communicable diseases such as diabetes and hypertension.
Amidst these challenges, rare diseases often slip through the cracks, affecting individuals and families in profound ways.
Enter Dr. Sabelo Vusi Dlamini, a seasoned public health expert and parasitologist, who has taken the helm of the Eswatini Health and Human Research Review Board (EHHRRB) as its new chair.
Dr. Dlamini brings a wealth of experience and qualifications to his new role, including a Doctor of Public Health (DrPH), Master of Science in Public Health (MScPH), Bachelor of Science (BSc), and certification as a Diabetes Educator (CDE).
As a Senior Lecturer at the Faculty of Health Sciences, University of Eswatini, Dr. Dlamini is well-positioned to drive change in the country's health research landscape.
In an exclusive interview, Dr. Dlamini shares the importance of creating awareness in tackling rare diseases in Eswatini.
"Unfortunately, many rare diseases are neglected in the country, suggesting that we need to create awareness through the Health Promotion department. This could also improve awareness among attending healthcare workers (diagnosing doctors and nurses) so that they think of the possibility of a patient developing a rare disease when first reporting for diagnoses. Health promotion could also empower parents of affected children to identify rare conditions early and to seek corrective measures," he explains.
He believes that creating awareness and gathering data on rare diseases are crucial steps towards improving diagnosis and treatment.
"We do need data on rare diseases which we can use to develop patient handling processes (diagnosis and management). Many rare diseases are neglected in the country, suggesting that we need to create awareness through the Health Promotion department," Dr. Dlamini says.
He further notes that rare diseases affect a few people and most of them are non-communicable. Their impact on communities or nationally is small but they have severe impact to the affected individual and close family members that have to take care of the affected individual.
When asked about the challenges in diagnosing rare diseases, Dr. Dlamini notes the healthcare professional such as the doctor, nurse, or other does not immediately think of the rare disease but focuses on the most common cause of the symptoms and treats according to that.
"This delays appropriate diagnosis of the rare disease," he says.
Dr. Dlamini further emphasizes the need for improved laboratory services, saying, "Lack of adequate laboratory services at some facilities limit progress to conclusive diagnosis, causing delay in confirmation of the rare disease."
Explaining the role of the EHHRRB, Dr. Dlamini says, "The Research Review Board has very little to do with healthcare practice but looks at the safety of research processes and does not conduct research itself."
He stresses the importance of research in understanding rare diseases, stating, "Research is supposed to determine the cause(s) of, for example, Blount disease in specific individuals whether it’s environmental, genetic or overload of bones from obesity."
Dr. Dlamini is further committed to prioritizing rare diseases.
The EHHRRB, under Dr. Dlamini's leadership, aims to strengthen the country's research ecosystem and promote ethical research practices.
Dr. Rejoice Nkambule, Deputy Director of Public Health in Eswatini's Ministry of Health, echoes this sentiment, saying, "The creation of the Board demonstrates Eswatini’s commitment to upholding international ethical standards, safeguarding rights and welfare of participants, and ensuring accountability and transparency in health and human research."
She explains that the EHHRRB will work closely with researchers, policymakers, and stakeholders to ensure that research is conducted with integrity and that findings are translated into policy and practice.
"The Board will also provide guidance on ethical issues, review research proposals, and monitor research activities to ensure compliance with national and international standards. We are committed to strengthening the research ecosystem in Eswatini and promoting a culture of research excellence and ethics," she further states.
Both Dr. Dlamini and Dr. Nkambule agree that strengthening Eswatini's research ecosystem is crucial for addressing rare diseases and promoting ethical research practices.
By creating awareness, gathering data, and ensuring research is conducted with integrity, Eswatini can better support individuals affected by rare diseases and contribute to the country's overall health development.